Maryland Heights, MO, January 22, 2017 --(PR.com
)-- The global cardiac prosthetic devices market is estimated to reach USD 5.8 Billion in 2020, expanding at a CAGR of 9.4% from 2016 to 2020, due to diabetes, hypertension and obesity disorders. Among the device segment, transcatheter heart valves and Implantable pacemakers registered the fastest growing segment of global cardiac prosthetic devices market. The same growth trends are likely to continue during the forecast period from 2016-2020. The rising prevalence of diabetes, hypertension and obesity disorders across the globe is driving the global cardiac prosthetic devices market.
Browse Cardiac Prosthetic Devices Market by Device Type (Heart Valves such as Mechanical Heart Valves, Tissue Heart Valves, Stented Tissue Valves, Transcatheter Heart Valves, and Pacemakers such as Implantable Pacemaker, Single-Chamber Battery Pacemaker, Dual-Chamber Battery Pacemaker, Triple-Chamber Battery Pacemaker, External Pacemaker) 2016-2020 at https://www.ihealthcareanalyst.com/report/cardiac-prosthetic-devices-market/.
Cardiac prosthetic devices are used to replace damaged or diseased natural valves of the heart. These devices increase the survival rate and improve the quality of life in most patients. The cardiac prosthetic devices encompass heart valves as well as pacemakers. Prosthetic cardiac devices improve survival and greatly increase the quality of life in most patients.1 Despite considerable advances in the technology behind prosthetic devices, these devices are still far from perfect, and ongoing changes continue to be made in an effort to enhance their function, effectiveness, and life expectancy. A variety of heart valves and pacemaker available in the market are mechanical heart valves, tissue heart valves, transcatheter heart valves, implantable pacemaker and external pacemaker.
The global cardiac prosthetic devices market segmentation is based on device type (heart valves such as mechanical heart valves, tissue heart valves, stented tissue valve, transcatheter heart valves, and pacemakers such as implantable pacemaker, single-chamber battery pacemaker, dual-chamber battery pacemaker, triple-chamber battery pacemaker, external pacemaker).
The global cardiac prosthetic devices market report provides market size (Revenue USD Million 2013 to 2020), market share, market trends and forecasts growth trends (CAGR%, 2016 to 2020). The global cardiac prosthetic devices market research report is segmented by geography (regional and country-based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global cardiac prosthetic devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major players operating in the global cardiac prosthetic devices market and included in this report are Abbott Laboratories, Boston Scientific, Medtronic, Inc., St. Jude Medical and others.
To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/cardiac-prosthetic-devices-market/.
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
2109 Mckelvey Hill Drive
Maryland Heights, MO 63043